Minimally invasive mitral valve repair for degenerative etiology: a comparative study

Abstract

Background

There is a paucity of data comparing the minimally invasive mitral valve repair (MiMVr) to the conventional approach in patients with degenerative disease. Our objective was to compare the outcomes of MiMVr to the traditional mitral valve repair through median sternotomy in patients with degenerative mitral valve disease. We conducted a retrospective study on 215 patients classified into two groups. Group 1 (n = 80) included those who had mitral valve repair through a right anterolateral video-assisted mini-thoracotomy, and group 2 (n = 135) was approached through a conventional median sternotomy. We compared the preoperative, operative, and postoperative data between groups. Both groups had echocardiographic follow-ups after 6 and 12 months.

Results

There was no difference in gender distribution between both groups, and patients who had median sternotomy were significantly older (median 37 (Q1-Q3, 29-44) vs. 54 (48-60) years; P < 0.001). Cardiopulmonary bypass (134.5 (130-138.5) vs. 99 (97-104) min; P < 0.001) and ischemic times (99 (95-105.5) vs. 78 (75-81) min; P < 0.001) were significantly shorter in patients who had median sternotomy. Patients with MiMVr had significantly lower blood loss (370 (315-390) vs. 550 (490-600) ml; P < 0.001) and ICU stay (5 (4.5-6) vs. 7 (7-8) days; P < 0.001). There was no difference between both groups regarding re-exploration for bleeding, postoperative stroke, wound infection, renal failure, and mortality. As regards postoperative echocardiography follow-up at 6 and 12 months after the operation, there were no significant changes in the mean mitral valve gradient within each group; however, the mean gradient was lower in the MiMVr group (3 (3-3.5) vs. 4 (3-5) mmHg; P < 0.001). There was no significant difference between both groups regarding mitral regurgitation severity during 6 and 12 months follow-up.

Conclusion

Minimally invasive mitral valve repair in patients with degenerative pathology could be an alternative to conventional mitral valve surgery with comparable short-term and long-term outcomes.

Background

Over the last few decades, minimally invasive surgery has transformed surgical practice, including various treatment options in heart surgery [1,2,3,4]. Minimally invasive surgery aims to achieve equivalent or better safety and efficacy than traditional surgery, with the added benefits of less trauma, better cosmesis, and shorter hospitalization. In the mid-1990s, video-assisted thoracotomy surgery was first used to do minimally invasive mitral valve surgery [5, 6]. Since then, several significant studies have established the viability of minimally invasive mitral valve repair (MiMVr) at specialist centers for selected patients [7,8,9].

Patients with symptomatic severe mitral regurgitation with or without impaired left ventricular function are indicated for mitral valve surgery [10]. Additionally, patients with asymptomatic mitral regurgitation but associated with pulmonary hypertension or significant left atrial dilatation could require surgery [10].

Despite positive institutional reviews, the MiMVr method had limited implementation. Previous meta-analyses found that minimally invasive mitral valve surgery had better perioperative outcomes than the traditional sternotomy approach. However, few attempts to distinguish repair from replacement procedures and account for the significant variations in the underlying valvular pathology were made [11, 12]. Furthermore, some surgeons are concerned about the mitral valve’s limited exposure, arterial damage, and difficulties deairing the heart, all of which could lead to an increase in cerebrovascular accidents [13]. Thus, our objective was to compare the outcomes of MiMVr to the traditional mitral valve repair through median sternotomy in patients with degenerative mitral valve disease.

Methods

This study was conducted on 215 patients who had mitral valve repair for degenerative disease. Patients had mitral valve repair either through a minimally invasive approach or sternotomy. This study was conducted over 10 years to collect this number of patients with isolated mitral valve disease. Variable techniques for repair were conducted in this study depending on the original pathology including artificial chordae where artificial gortex stitches added from the anterolateral and the posteromedial papillary muscles and sutured to the free edges of both anterior and posterior leaflet to adjust the point of coaptation of both leaflets together preventing mitral regurge or resection of the prolapsed midscallop of the posterior leaflet and placement of a flexible annuloplasty ring. Correction of the anterior leaflet by limited resection, chordal transfer from posterior to anterior leaflet, and, in these cases, replacement of anterior leaflet chordae by polytetrafluoroethylene sutures and also commissural stitches which may complicate later with mitral stenosis associated with increase mean pressure over mitral valve; for all cases, ring annuloplasty were done in addition to the other techniques mentioned before. We included patients who had elective isolated mitral valve repair with normal coronary arteries and no end-organ damage. We excluded patients older than 70 or younger than 16 years with ischemic or rheumatic mitral valve disease and those with infective endocarditis. We also excluded emergency cases and patients with concomitant valve or coronary artery lesions and end-organ failure (stroke, renal, or hepatic failure). The same surgeons performed the operations in both groups with the same technique. Selecting patients to either group was based on surgeons’ preference. The study was approved by the local Ethical Committee, and consent to participate was waived because of the retrospective design. The study was conducted according to the Declaration of Helsinki.

The patients were grouped into two groups according to the surgical approach. Group 1 included patients who had MiMVr through a right anterolateral video-assisted mini-thoracotomy, and group 2 had a median sternotomy.

Baseline characteristics of patients were collected, including age, gender, and comorbidities. Intraoperative data included cross-clamp and cardiopulmonary bypass times. Postoperative outcomes were blood loss or need for blood transfusion, ICU stay, sternal wound infection, the occurrence of renal failure or stroke, and hospital mortality.

In addition, patients were followed with echocardiography at 6 and 12 months postoperatively to assess the severity of mitral regurgitation, the mean pressure gradient across the mitral valve, and the need for mitral valve reoperation.

Statistical analysis

Wilcoxon test was used to compare the quantitative data, which were presented as median and interquartile range. The Chi-square and Fisher exact tests were used to compare the qualitative data, which were presented as frequency and percentages. Linear regression analysis was used to identify factors affecting cross-clamp and cardiopulmonary bypass times. Repeated measure ANOVA was used to test the changes in the mean mitral valve gradient. A random-effect model was used to test the factors affecting the change in mitral valve gradient during follow-up. Stata 16.1 was used to perform the statistical analysis (Stata Corp., College Station, TX, USA).

Results

Preoperative and operative data

There was no difference in gender distribution between both groups (P = 0.4), and patients who had median sternotomy were significantly older (P < 0.001) (Table 1). Cardiopulmonary bypass and ischemic times were significantly shorter in patients who had a median sternotomy. Six patients (7.5%) required repair revision in group 1 compare to three (2.22%) patients in group 2 (P = 0.08) (Table 1). Surgical approach was the only factor associated with reduced cross-clamp and cardiopulmonary bypass times (Table 2).

Table 1 Preoperative and operative data

Table 2 Multivariable analysis of factors affecting cardiopulmonary bypass and ischemic times

Postoperative outcomes

Patients in group 1 had significantly lower blood loss and hospital stay. There was no difference in re-exploration for bleeding, postoperative stroke, wound infection, renal failure, and mortality between groups (Table 3). After adjusting for the preoperative and operative variables, blood loss did not differ significantly between groups (Table 4). The cause of the mortality in the study was ruptured A-V groove which occurred from the presence of annular calcification extending deep in the annulus to the atrioventricular groove and during decalcification of the annulus to create safe area for the mitral ring to be sutured disruption of the A-V groove occurred with severe uncontrolled bleeding. The cause of post-operative mitral stenosis occurred in the post repair of the mitral valve with commissural stitch that complicated with fibrosis and narrowing of the orifice area of mitral valve and so increase the gradient on mitral valve.

Table 3 Postoperative outcomes

Table 4 Factors affecting postoperative blood loss

Follow-up data

There were no significant changes in the mean mitral valve gradient at 6 and 12 months within each group (P = 0.1); however, the mean gradient is different significantly between both groups (P < 0.001) (Fig. 1). Four patients in group 1 had moderate mitral regurgitation at 6 months. Two of them regressed to mild-moderate mitral regurgitation at 1 year, and two progressed to severe mitral regurgitation. Three patients had moderate mitral regurgitation at 6 months in group 2; two of them regressed to mild-moderate MR, and one progressed to severe MR at 1 year. Three patients in group 1 had mitral valve reoperation for severe MR (n = 2) and severe MS (n = 1) after 1 year; for this patient, commissural stitch was done and so it was complicated with mitral stenosis. One patient in group 2 had mitral valve reoperation for severe MR at 1 year (Table 5). After adjusting the preoperative factors, the group did not affect the change in mitral valve gradient (Table 6).

Fig. 1

Change in the mean mitral valve gradient between groups

Table 5 Follow-up data

Table 6 Factors affecting the change of the mitral valve gradient

Discussion

Operating on symptomatic mitral regurgitation is increasing and requires refining the surgical techniques to minimize the complications and improve the long-term sequences [14]. Median sternotomy is the standard approach for mitral valve surgery; however, it has suboptimal cosmetic results and the risk of sternal wound infection and long healing time. These factors could affect the return to normal physical activity. Minimally invasive approaches overcome many of these drawbacks [15]. The most common minimally invasive approach is through the right mini-thoracotomy.

In our study, the patients’ basic characteristics differed significantly regarding the age where the patients who underwent the MIMVr were younger than those who underwent the conventional approach. Additionally, logistic EuroSCORE was significantly higher in the conventional group, where the average EuroSCORE of this group was 6.8 compared to 3.6 as an average in the group who did MiMVr. This finding reflects our early experience with the minimally invasive approaches in selecting low-risk patients to minimize the complications and improve the learning curve. There was no statistically significant difference in gender, renal function, preoperative rhythm, and EF between groups.

Regarding CPB and cross-clamp times, it was found that they were more prolonged in the MiMVr group. The average CPB time in the MiMVr group was 134.5 (130-138.5) compared to 99 (97-104) in the conventional group, and the cross-clamp time was 99 (95-105.5) in the MiMVr group compared to 78 (75-81) in the conventional group. These results are concordant with other studies [16], which could be the effect of learning experiences and the setup for the minimally invasive approach.

In addition, the reopening for bleeding and need for blood transfusion was less in patients with MiMVr but with no significant difference. This result is not concordant with other studies [16,17,18], where the bleeding and need for blood transfusion were statistically less in patients with MiMVr than those with the conventional method. This can be explained by the lower number of patients in each group, and increasing the sample size could make this difference more significant [17].

Moreover, the in-hospital mortality did not differ between groups in concordant with Jackson and colleagues’ study [19]. Patients in the MiMVr group had lower blood loss and ICU stay, which could improve the long-term outcomes. There was no significant difference in reoperation rate between groups after 1-year follow-up. This result was similar to others [16, 18]. Comparing both groups regarding postoperative echocardiographic findings yielded no significant difference between both groups in recurrence of moderate mitral incompetence and the mean gradient across mitral valve both immediately postoperative and during 1 year follow-up. These results are similar to Christopher and associates’ study [1], which showed the same satisfactory echocardiographic outcome in both groups. Still, in Jackson et al.’s study, there was a higher recurrence of moderate mitral incompetence with median sternotomy than those with MiMVr. The mean pressure gradient across the mitral valve in the conventional group increased with a higher value than those with the MiMVr group but was not statistically significant [19].

Study limitations

The study is limited by the retrospective design and the sample size. Additionally, it is a single-center experience, and generalization of the results may be an issue. The results of the study may be affected by our early experience in minimally invasive approaches as most of complications for minimal invasive approach occurred in the early years of this study; limitations of available data as the baseline echo for all operated cases with baseline gradient across mitral valve and also the detailed technique of repair for each case as this study is carried over 10 years with defect in adequate automated recording of these data in the early years of the study. Surgeon preference is one of the causes of the limitations as most surgeon will chose easy cases that require simple repair technique in minimal invasive cases.

Conclusions

Minimally invasive mitral valve repair in patients with degenerative etiology is one of the options that can be applied safely depending on the experience and the available set up and can be an alternative to the conventional approach with comparable short and early long-term results.